+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV



Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV



Antibiotiki i Khimioterapiia 56(7-8): 42-46



Foreign experience with empirical management of severe acute respiratory syndrome (SARS) due to coronavirus, genotype IV is described. It is indicated that the data on the efficacy of ribavirin with respect to SARS in the patients are contradictory. The efficacy of two chemotherapeutics, i. e. lopinavir and ritonavir used in the SARS foci is confirmed. The drugs are at present applicable all over the world in retrovirus therapy of HIV infected subjects. The search for efficient Russian unspecific medicines for control of SARS is actual.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 053125727

Download citation: RISBibTeXText

PMID: 22359870


Related references

Severe acute respiratory syndrome-associated coronavirus genotype and its characterization. Chinese Medical Journal 116(9): 1288-1292, 2003

Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus. Journal of Virology 81(24): 13681-13693, 2007

Three dimensional model of severe acute respiratory syndrome coronavirus helicase ATPase catalytic domain and molecular design of severe acute respiratory syndrome coronavirus helicase inhibitors. Journal of Computer-Aided Molecular Design 20(5): 305-319, 2006

High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus. Clinical and Vaccine Immunology 14(12): 1644-1645, 2007

Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers. Current Opinion in Infectious Diseases 27(5): 411-417, 2014

The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line. Chinese Medical Journal 118(4): 267-274, 2005

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). Journal of Biological Chemistry 291(17): 9218-9232, 2016

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. Journal of Virology 90(19): 8924-8933, 2016

Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome. Antibiotiki i Khimioterapiia 56(9-10): 41-46, 2011

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiology and Molecular Biology Reviews 69(4): 635-664, 2005

Severe acute respiratory syndrome coronavirus protein 6 accelerates murine coronavirus infections. Journal of Virology 81(3): 1220-1229, 2007

Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol. Respirology 9(2): 173-183, 2004

Human coronavirus EMC is not the same as severe acute respiratory syndrome coronavirus. Mbio 4(1):, 2013

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proceedings of the National Academy of Sciences of the United States of America 102(22): 7988-7993, 2005

A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus. Journal of Virology 79(17): 11335-11342, 2005